AFM13 in Combination with Allogeneic Natural Killer Cells (AB-101) in Relapsed or Refractory Hodgkin Lymphoma and CD30+ Peripheral T-Cell Lymphoma: A Phase 2 Study (LuminICE-203)
Moskowitz et al.
ASH 2023
Moskowitz et al.
ASH 2023
Tasser et al.
PEGS-EU
Ciulean et al.
SITC 2023
Pahl et al.
NK2023
Müller, Tasser et al.
mAbs, ePub ahead of print
El-Khoueiry et al.
ASCO Brekathrough 2023
17-ICML
Pahl et al.
EHA 2023
Kim et al.
El-Khoueiry et al.
ASCO 2023
Zambarda et al.
AACR 2023